Stock Information
Kiniksa Pharmaceuticals International PLC (KNSA)
Ticker Symbol: KNSA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $5,994.24 mil
Piotroski score: 8
PE Ratio: 73.19
EPS (TTM): 0.98
Revenue (TTM): $10.08 M
Dividend Yield: N/A
ROE: 13.65%
Latest News
-
Kiniksa Pharmaceuticals International (KNSA) On The ARCALYST Story And Whether Shares Look Fully Valued
Wed, Sep 23, 2026 11:14 PM
-
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Meets Minervini Trend Template and High-Growth Momentum Criteria
Wed, Sep 23, 2026 8:41 AM
-
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Combines Strong Growth With a High-Quality Technical Setup
Fri, Sep 18, 2026 8:40 AM
-
Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why
Thu, Sep 17, 2026 4:13 PM
Key Financials
Financial data not available